Loss of heterozygosity and tumor suppressor gene mutations in chondrosarcomas

Anticancer Research

Volumn 16, Issue 4 A, 1996, Pages 2009-2015

  Yamaguchi, Toshikazu ^a   Toguchida, Junya ^a   Wadayama, Bun Ichiro ^a   Kanoe, Hiroshi ^a   Nakayama, Tomitaka ^a   Ishizaki, Kanji ^a   Ikenaga, Mituo ^a   Kotoura, Yoshihiko ^a   Sasaki, Masao S ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Chondrosarcoma; Heterozygosity; Tumor suppressor gene mutations

Indexed keywords

PROTEIN P53; RETINOBLASTOMA PROTEIN;

ADULT; AGED; ARTICLE; CANCER GENETICS; CANCER GRADING; CHONDROSARCOMA; CHROMOSOME 13Q; CHROMOSOME 17P; CLINICAL ARTICLE; FEMALE; GENE LOSS; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; MALE; POINT MUTATION; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ADOLESCENT; ADULT; AGED; ALLELES; AMINO ACID SEQUENCE; BASE SEQUENCE; BONE NEOPLASMS; CHONDROSARCOMA; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 13; CHROMOSOMES, HUMAN, PAIR 17; FEMALE; GENE DELETION; GENES, P53; GENES, RETINOBLASTOMA; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; NEOPLASM METASTASIS; NEOPLASM STAGING; POINT MUTATION; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; RECURRENCE;

EID: 0029764225     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Knudson AG: Antioncogenes and human cancer. Proc Natl Acad Sci USA 90: 10914-10921, 1993.
2. Friend SH, Horowitz JM, Gerber MR et al: Deletion of a DNA sequence in retinoblastomas and mesenchymal tumors: organization of the sequence and its encoded protein. Proc Natl Acad Sci USA 84: 9059-9063, 1987.
3. Toguchida J, Ishizaki K, Sasaki MS, et al: Chromosomal reorganization for the expression of recessive mutation of retinoblastoma susceptibility gene in the development of osteosarcoma. Cancer Res 48: 3939-3943, 1988.
4. Reissmann PT, Simon MA, Lee W-H, et al: Studies of the retinoblastoma gene in human sarcomas. Oncogene 4: 839-843, 1989.
5. Mulligan LM, Matlashewski GJ, and Scrable HJ, et al: Mechanisms of p53 loss in human sarcomas. Proc Natl Acad Sci USA 87: 5863-5867, 1990.
6. Toguchida J, Yamaguchi T, and Ritchic B, et al: Mutation spectrum of the p53 gene in hone and soft tissue sarcomas. Cancer Res 52: 6194-6199, 1992.
7. Wadayama B, Toguchida J, Shimizu T, et al: Mutation spectrum of the retinoblastoma gene in osteosarcomas. Cancer Res 54: 3042-3048, 1994.
8. Cavenee WK, Dryja TP, Phillips RA, et al: Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature 30: 5779-5784, 1983.
9. Dahlin DC: Chondrosarcoma in Bone Tumors. Third Edition. Springfield, Charles C Thomas Publisher. p190-217. 1978.
10. Peterson HA: Multiple hereditary osteochondroma. Clin Orthop 239: 222-230, 1989.
11. Evans HL, Ayala AG, and Romsdahl MM: Prognostic factors in chondrosarcoma of hone. A clinicopathologic analysis with emphasis on histologic grading. Cancer 40: 818-831, 1977.
12. Dahlin DC, and Beabout JW: Dedifferentiation of low-grade chondrosarcomas. Cancer 28: 461-466, 1971.
13. Schwartz HS, Zimmerman NB, Simon MA, et al: The malignant potential of enchondromatosis. J Bone and Joint Surg 63-A: 269-274, 1987.
14. Maniatis T, Fritsh EF, and Sambrook J: Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1982.
15. Buchman VL, Chumakov PM, Ninkina NN, et al. A variation in the structure of the protein-coding region of the human p53 gene. Gene 70: 245-252, 1988.
16. Calle-Martin OdL, Fabregat V, Romero M, et al: AccII polymorphism of the p53. Nucleic Acid Res 18: 4963, 1990.
17. Toguchida J, Ishizaki K, Nakamura Y, et al: Assignment of common allele loss in osteosarcoma to the subregion 17p13. Cancer Res 49: 6247-6251, 1989.
18. Yamaguchi T, Toguchida J, Yamamuro T, et al: Allelotype analysis in osteosarcomas: frequent allele loss on 3q, 13q, 17p, and 18q. Cancer Res 52: 2419-2422, 1992.
19. Liu Y, Szekely L, Grander D, et al: Chronic Iymphocytic leukemia cells with allelic deletions at 13q14 commonly have one intact RB1 gene: evidence for a role of an adjacent locus. Proc Natl Acad Sci USA 90: 8697-8701, 1993.
20. Willeret JR, Daneshvar L, Sheffield VC, et al: Deletion of chromosome arm 17p DNA sequences in pediatric high-grade and juvenile pilocytic astrocytomas. Gene Chromosom Cancer 12: 165-172, 1995.
21. Ahn J, Ludecke H-J, Lindow S, et al: Cloning of the putative tumour suppressor gene for hereditary multiple exostosis (EXT1). Nat Genet 11: 137-143, 1995.
22. Hecht JT, Hogue D, Strong LC, et al: Hereditary multiple exostosis and chondrosarcoma: linked to chromosome 11 and loss of heterozygosity for EXTlinked markers on chromosomes 11 and 8. Am J Hum Genet 56: 1125-1131, 1995.
23. Raskind WH, Conrad EU, Chanskyu H, et al: Loss of heterozygosity in chondrosarcomas for markers linked to hereditary multiple exostosis loci on chromosomes. Am J Hum Genet 56: 1132-1139, 1995.
24. Fearon ER and Vogelstein B: A genetic model for colorectal tumorigenesis. Cell 61: 759-767, 1990.
25. Healey JH, and Lane JM: Chondrosarcoma Clin Orthop 204: 119-129, 1986.
26. Dobashi Y, Sugimura H, Sato A, et al: Possible association of p53 overexpression and mutation with high-grade chondrosarcoma. Diag Mol Path 2: 257-263, 1993.
27. Nakayama T, Toguchida J, Wadayama B, et al: MDM2 gene amplification in bone and soft tissue tumors: association with tumor progression in differentiated adipose tissue tumors. Int J Cancer 64: 342-346, 1995.